Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Some new insights in intestinal failure-associated liver disease.

Goulet O, Joly F, Corriol O, Colomb-Jung V.

Curr Opin Organ Transplant. 2009 Jun;14(3):256-61. doi: 10.1097/MOT.0b013e32832ac06f. Review.

PMID:
19444108
2.

Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil.

Fallon EM, Le HD, Puder M.

Curr Opin Organ Transplant. 2010 Jun;15(3):334-40. Review.

PMID:
20503524
3.

The use of fish oil lipid emulsion in the treatment of intestinal failure associated liver disease (IFALD).

Chang MI, Puder M, Gura KM.

Nutrients. 2012 Nov 27;4(12):1828-50. doi: 10.3390/nu4121828. Review.

4.

Prevention of parenteral nutrition-associated liver disease: lipid minimization.

Cober MP, Teitelbaum DH.

Curr Opin Organ Transplant. 2010 Jun;15(3):330-3. doi: 10.1097/MOT.0b013e328338c2da. Review.

PMID:
20386446
5.

Fish oil emulsions in the management of intestinal failure-associated liver disease.

Mercer DF.

J Clin Gastroenterol. 2012 Nov-Dec;46(10):823-7. doi: 10.1097/MCG.0b013e318261836d. Review.

PMID:
23060217
6.

Use of an omega-3 fatty acid-based emulsion in the treatment of parenteral nutrition-induced cholestasis in patients with microvillous inclusion disease.

Fuchs J, Fallon EM, Gura KM, Puder M.

J Pediatr Surg. 2011 Dec;46(12):2376-82. doi: 10.1016/j.jpedsurg.2011.09.061. Review.

PMID:
22152886
7.

Intravenous lipid emulsions in pediatric patients with intestinal failure.

Goulet O, Lambe C.

Curr Opin Organ Transplant. 2017 Apr;22(2):142-148. doi: 10.1097/MOT.0000000000000396. Review.

PMID:
28267037
8.

Fish oil containing intravenous lipid emulsions in parenteral nutrition-associated cholestatic liver disease.

Koletzko B, Goulet O.

Curr Opin Clin Nutr Metab Care. 2010 May;13(3):321-6. doi: 10.1097/MCO.0b013e3283385407. Review.

PMID:
20393276
9.

Treatment of parenteral nutrition-associated liver disease: the role of lipid emulsions.

Nandivada P, Carlson SJ, Chang MI, Cowan E, Gura KM, Puder M.

Adv Nutr. 2013 Nov 6;4(6):711-7. doi: 10.3945/an.113.004770. eCollection 2013 Nov. Review.

10.

Lipid emulsions in the treatment and prevention of parenteral nutrition-associated liver disease in infants and children.

Nandivada P, Fell GL, Gura KM, Puder M.

Am J Clin Nutr. 2016 Feb;103(2):629S-34S. doi: 10.3945/ajcn.114.103986. Epub 2016 Jan 20. Review.

11.

Impact of new-generation lipid emulsions on cellular mechanisms of parenteral nutrition-associated liver disease.

Burrin DG, Ng K, Stoll B, Sáenz De Pipaón M.

Adv Nutr. 2014 Jan 1;5(1):82-91. doi: 10.3945/an.113.004796. Review.

12.

Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment.

Orso G, Mandato C, Veropalumbo C, Cecchi N, Garzi A, Vajro P.

Dig Liver Dis. 2016 Mar;48(3):215-22. doi: 10.1016/j.dld.2015.11.003. Epub 2015 Nov 14. Review.

PMID:
26698410
13.

Nutritional management of infants with short bowel syndrome.

Wessel JJ, Kocoshis SA.

Semin Perinatol. 2007 Apr;31(2):104-11. Review.

PMID:
17462495
14.

Comparison of Formulas Based on Lipid Emulsions of Olive Oil, Soybean Oil, or Several Oils for Parenteral Nutrition: A Systematic Review and Meta-Analysis.

Dai YJ, Sun LL, Li MY, Ding CL, Su YC, Sun LJ, Xue SH, Yan F, Zhao CH, Wang W.

Adv Nutr. 2016 Mar 15;7(2):279-86. doi: 10.3945/an.114.007427. Print 2016 Mar. Review.

15.

The impact of intravenous fish oil emulsions on pediatric intestinal failure-associated liver disease.

Venick RS, Calkins K.

Curr Opin Organ Transplant. 2011 Jun;16(3):306-11. doi: 10.1097/MOT.0b013e32834670eb. Review.

PMID:
21505340
16.

Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience.

de Meijer VE, Gura KM, Le HD, Meisel JA, Puder M.

JPEN J Parenter Enteral Nutr. 2009 Sep-Oct;33(5):541-7. doi: 10.1177/0148607109332773. Epub 2009 Jul 1. Review.

PMID:
19571170
17.

Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease.

de Meijer VE, Gura KM, Meisel JA, Le HD, Puder M.

Arch Surg. 2010 Jun;145(6):547-51. doi: 10.1001/archsurg.2010.80. Review.

PMID:
20566974
18.

Fish oil-based lipid emulsions in the treatment of parenteral nutrition-associated liver disease: an ongoing positive experience.

Premkumar MH, Carter BA, Hawthorne KM, King K, Abrams SA.

Adv Nutr. 2014 Jan 1;5(1):65-70. doi: 10.3945/an.113.004671. Review.

19.

Fish oil lipid emulsions and immune response: what clinicians need to know.

Waitzberg DL, Torrinhas RS.

Nutr Clin Pract. 2009 Aug-Sep;24(4):487-99. doi: 10.1177/0884533609339071. Review.

PMID:
19605803
20.

What is the current role for parenteral lipid emulsions containing omega-3 fatty acids in infants with short bowel syndrome?

Diamond IR, Pencharz PB, Wales PW.

Minerva Pediatr. 2009 Jun;61(3):263-72. Review.

PMID:
19461570

Supplemental Content

Support Center